JCR Pharmaceuticals.
$9.04
0
-$1.07-10.58% Wednesday 17:40
Statistics
Day High
9.04
Day Low
9.04
52W High
19.24
52W Low
9.04
Volume
500
Avg. Volume
9
Mkt Cap
2.5B
P/E Ratio
0
Dividend Yield
1.49%
Dividend
0.13
Upcoming
Dividends
1.49%Dividend Yield
Dec 23
$0.07
Jun 23
$0.08
Dec 22
$0.07
Jun 22
$0.02
Jun 22
$0.08
Earnings
25OctConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-3.29
18.56
40.42
62.27
Expected EPS
0.1
Actual EPS
-3.29
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JCRRF. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Show more...
CEO
Mr. Shin Ashida
Employees
816
Country
JP
ISIN
JP3701000006